These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14578259)

  • 1. The coming of age of the metabolic syndrome.
    Alexander CM
    Diabetes Care; 2003 Nov; 26(11):3180-1. PubMed ID: 14578259
    [No Abstract]   [Full Text] [Related]  

  • 2. Is metabolic syndrome X an inflammatory condition?
    Das UN
    Exp Biol Med (Maywood); 2002 Dec; 227(11):989-97. PubMed ID: 12486208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
    Rizvi AA; Stoian AP; Rizzo M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the cardiometabolic syndrome.
    Sowers JR
    Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome.
    Summers SA; Nelson DH
    Diabetes; 2005 Mar; 54(3):591-602. PubMed ID: 15734832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus.
    Volpe SL
    Crit Rev Food Sci Nutr; 2008 Mar; 48(3):293-300. PubMed ID: 18274977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes.
    De Cosmo S; Trevisan R; Minenna A; Vedovato M; Viti R; Santini SA; Dodesini AR; Fioretto P; Trischitta V
    Diabetes Care; 2006 Feb; 29(2):432-4. PubMed ID: 16443904
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolic syndrome: the emperor needs some consistent clothes.
    Vinicor F; Bowman B
    Diabetes Care; 2004 May; 27(5):1243; author reply 1244. PubMed ID: 15111565
    [No Abstract]   [Full Text] [Related]  

  • 9. Redox implications in adipose tissue (dys)function--A new look at old acquaintances.
    Jankovic A; Korac A; Buzadzic B; Otasevic V; Stancic A; Daiber A; Korac B
    Redox Biol; 2015 Dec; 6():19-32. PubMed ID: 26177468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic syndrome, resistance to insulin and diabetes. What is hidden beneath the tip of the iceberg?].
    Costa B; Cabré JJ; Martín F
    Aten Primaria; 2003 Apr; 31(7):436-45. PubMed ID: 12735887
    [No Abstract]   [Full Text] [Related]  

  • 11. Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome.
    Anthanont P; Ramos P; Jensen MD; Hames KC
    Int J Obes (Lond); 2017 Nov; 41(11):1621-1626. PubMed ID: 28736442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.
    Bloomgarden ZT
    Diabetes Care; 2010 Jul; 33(7):e85-9. PubMed ID: 20587709
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus.
    Simonson GD; Kendall DM
    Coron Artery Dis; 2005 Dec; 16(8):465-72. PubMed ID: 16319655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome.
    Kreier F; Yilmaz A; Kalsbeek A; Romijn JA; Sauerwein HP; Fliers E; Buijs RM
    Diabetes; 2003 Nov; 52(11):2652-6. PubMed ID: 14578282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Magnesium, diabetes and metabolic syndrome].
    Barbagallo M; Domínguez LJ
    Cir Cir; 2013; 81(5):365-7. PubMed ID: 25125052
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Frontoni S
    Diabetes; 2013 Jan; 62(1):e1. PubMed ID: 23258917
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin action and resistance in obesity and type 2 diabetes.
    Czech MP
    Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?
    Meas T
    Diabetes Metab; 2010 Feb; 36(1):11-20. PubMed ID: 19815442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Straznicky NE; Lambert EA; Lambert GW
    Diabetes; 2013 Jan; 62(1):e2. PubMed ID: 23258918
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.
    Forst T; Hohberg C; Pfützner A
    Horm Metab Res; 2009 Feb; 41(2):123-31. PubMed ID: 19214922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.